Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 110
Filter
1.
Lett Appl Microbiol ; 67(3): 214-219, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29893497

ABSTRACT

Biofilms, composed of bacterial cells embedded in a secreted polysaccharide and protein matrix, often cause problems such as chronic and refractory infections. Staphylococcus pseudintermedius, which is an important pathogen in veterinary medicine, has a high rate of biofilm production. Although it is considered that S. pseudintermedius biofilms are associated with prolonged inflammatory disorders, there are no reports that S. pseudintermedius biofilm directly regulates inflammatory reactions. In this study, we focused on the metabolites derived from biofilm cultures of S. pseudintermedius and evaluated their inflammatory effects in vitro. Expression levels of interleukin-1 beta and interleukin-6 mRNA significantly increased in RAW264.7 cells that were cultured with biofilm-conditioned medium (BCM). The secreted proteins in BCM were heat resistance and activated a Toll-like receptor (TLR) signalling pathway. Moreover, based on SDS-PAGE analysis, isolates with stronger biofilm-forming capabilities induced more inflammatory reactions and had specific banding patterns compared with those of weak biofilm producers. Collectively, our results suggest that the proteins derived from S. pseudintermedius biofilm induce a host inflammatory response via a TLR pathway. Furthermore, the severity of inflammation depends on the biofilm formation capacity of the S. pseudintermedius strain. SIGNIFICANCE AND IMPACT OF THE STUDY: Staphylococcus pseudintermedius is a biofilm-forming bacterium. We identified some biofilm secreted heat-resistant proteins that induce inflammatory reactions through Toll-like receptor signalling. The expression of the secreted protein varied depending on the potency of biofilm production. Our data suggest that these proteins may be the factors causing biofilm-related inflammation during S. pseudintermedius infections. Identification of these proteins may lead to the development of novel medications to prevent the exacerbation of infections caused by S. pseudintermedius.


Subject(s)
Biofilms , Staphylococcal Infections/immunology , Staphylococcus/physiology , Animals , Culture Media, Conditioned/chemistry , Culture Media, Conditioned/metabolism , Humans , Interleukin-1beta/genetics , Interleukin-1beta/immunology , Interleukin-6/genetics , Interleukin-6/immunology , Macrophages/drug effects , Macrophages/immunology , Mice , RAW 264.7 Cells , Staphylococcal Infections/genetics , Staphylococcal Infections/microbiology , Staphylococcus/genetics
2.
Blood Cancer J ; 3: e150, 2013 Oct 04.
Article in English | MEDLINE | ID: mdl-24096714

ABSTRACT

The proteasome inhibitor bortezomib has revolutionized the treatment of multiple myeloma. However, bortezomib-induced peripheral neuropathy (BiPN) is a serious complication that compromises clinical outcome. If patients with a risk of developing BiPN could be predicted, physicians might prefer weekly, reduced-dose, or subcutaneous approaches. To seek biomarkers for BiPN, we conducted a multicenter prospective study using a simple and unique system. Multiple myeloma patients received twice-weekly or weekly 1.3 mg/m(2) bortezomib intravenously, and a 2-ml sample of whole blood was obtained before treatment and 2-3 days and 1-3 weeks after the first dose. Induction of gene expression was then quantified by real-time PCR. Of a total of 64 enrolled patients, 53 patient samples qualified for mRNA analysis. The BiPN grade was associated with phytohemagglutinin-induced IL2, IFNG and TNFSF2, as well as with lipopolysaccharide-induced IL6 levels. More importantly, of the 19 patients showing a 3-fold increase in phytohemagglutinin-induced IL2, 14 did not suffer from BiPN (73.7% prediction), whereas of the 34 patients with a <3-fold increase, 23 experienced BiPN (67.6% prediction). Therefore, we concluded that pretreatment of phytohemagglutinin-induced IL2 mRNA levels in whole blood serve as a promising biomarker for predicting BiPN, and this finding warrants validation in a larger study.

3.
Open Biomed Eng J ; 6: 98-103, 2012.
Article in English | MEDLINE | ID: mdl-23115598

ABSTRACT

We evaluated effects of an injectable complex of ß-tricalcium phosphate (ß-TCP) granules, hyaluronate, and recombinant human fibroblast growth factor-2 (rhFGF-2) on repair of unstable intertrochanteric fractures in elderly patients. Twenty-five patients (range, 76-91 years) having 31.A2 fractures (AO classification) were treated with injection of the complex followed by intramedullary nails. Bone regeneration and ß-TCP resorption, unions of intertrochanteric fractures and displaced lesser trochanters to the shaft, and varus deformity of the femoral neck were assessed by X-ray and CT scans. Fracture union occurred in all cases and union of the displaced lesser trochanter to the shaft was obtained in 24 cases by 12 weeks. It is of interest that ß-TCP granules were completely replaced by bone and marked new bone formation around the lesser trochanter was observed in all cases compared to cases not treated with the complex. This complex is a paste-like material that is easy to handle, and it may be of considerable use in treatment of both unstable intertrochanteric fractures and other cortical bone defects with minimal surgical invasion.

4.
Diabetologia ; 54(8): 2056-66, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21567299

ABSTRACT

AIMS/HYPOTHESIS: TNF-α plays important roles in the pathogenesis of type 1 and type 2 diabetes mellitus. In light of this, we examined the involvement of a pro-apoptotic gene, BBC3 (also known as PUMA), in TNF-α-mediated beta cell dysfunction and destruction in human islets. METHODS: Human islets were exposed in vitro to TNF-α alone or in combination with IFN-γ. Gene expression was assessed by RT-PCR using a set of single islets. Protein abundance and cellular localisation of BBC3 were assessed by immunoblot and immunohistochemistry. A marginal number of islets were transplanted into diabetic NODscid mice to correlate in vivo islet function with BBC3 expression. RESULTS: BBC3 and IL8 mRNA were upregulated in TNF-α-stimulated islets in a dose-dependent manner and enhanced through addition of IFN-γ, but not upregulated by IFN-γ alone. Immunohistochemistry revealed that TNF-α in combination with IFN-γ upregulated basal BBC3 abundance in the cytoplasm of beta cells along with the perinuclear clustering of mitochondria partially co-localised with BBC3. TNF-α alone did not induce beta cell death, but did abrogate preproinsulin precursor mRNA synthesis in response to high glucose stimulation, which was inversely associated with upregulation of BBC3 mRNA expression by TNF-α. Higher BBC3 mRNA expression in islets correlated with decreased graft function in vivo. CONCLUSIONS/INTERPRETATION: These results suggest that BBC3 mRNA can serve as a molecular marker to detect early TNF-α-induced beta cell stress and may help identify islet-protective compounds for the treatment of diabetes.


Subject(s)
Apoptosis Regulatory Proteins/metabolism , Cell Death/drug effects , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Proto-Oncogene Proteins/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Adult , Aged , Animals , Apoptosis Regulatory Proteins/genetics , Blotting, Western , Cells, Cultured , Female , Flow Cytometry , Humans , Immunohistochemistry , In Vitro Techniques , Insulin-Secreting Cells/cytology , Insulin-Secreting Cells/drug effects , Insulin-Secreting Cells/metabolism , Interferon-gamma/pharmacology , Interleukin-8/metabolism , Male , Mice , Mice, Inbred NOD , Mice, SCID , Middle Aged , Proto-Oncogene Proteins/genetics , Young Adult
5.
Dis Esophagus ; 17(4): 315-21, 2004.
Article in English | MEDLINE | ID: mdl-15569370

ABSTRACT

Chemoradiotherapy is a multimodal therapy routinely used as a primary treatment for advanced esophageal cancer. However, it is beneficial only to patients who respond. To identify pretreatment markers predicting response and survival, we examined the expression of cell cycle regulatory molecules, p53, p21(Waf1/Cip1) cyclin D1, and CDC25B, in biopsy specimens from 76 patients with stage III and stage IV squamous cell carcinoma. Overexpression of p53, p21, cyclin D1 and CDC25B was observed in 58%, 30%, 28%, and 32% of patients, respectively. The expression of p21 correlated significantly with response to chemoradiotherapy (P = 0.0001). Survival of patients with p21-expressing tumors was better than that of patients with p21-negative tumors (P = 0.013). Expression of other genes was not significantly correlated with treatment response and survival. In patients with p53-negative tumors, survival of those patients with p21-positive tumors was significantly higher than that of those with p21-negative tumors (P = 0.0452), but no significant difference was found in patients with p53-positive tumors. Multivariate analysis revealed that p21 expression was an independent variable among pretreatment parameters in predicting survival. These results suggest that p21 expression is potentially useful for predicting the response to chemoradiotherapy and survival of patients with advanced esophageal squamous cell cancer.


Subject(s)
Carcinoma, Squamous Cell/therapy , Cell Cycle Proteins/analysis , Esophageal Neoplasms/therapy , Gene Expression Regulation, Neoplastic , Biopsy , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/mortality , Cell Cycle Proteins/genetics , Chemotherapy, Adjuvant , Cyclin D1/analysis , Cyclin D1/genetics , Cyclin-Dependent Kinase Inhibitor p21 , Esophageal Neoplasms/metabolism , Esophageal Neoplasms/mortality , Female , Humans , Immunohistochemistry , Male , Multivariate Analysis , Prognosis , Proportional Hazards Models , Radiotherapy, Adjuvant , Survival Rate , Treatment Outcome , Tumor Suppressor Protein p53/analysis , Tumor Suppressor Protein p53/genetics , cdc25 Phosphatases/analysis , cdc25 Phosphatases/genetics
6.
Biotechniques ; 32(5): 1014-6, 1018, 1020, 2002 May.
Article in English | MEDLINE | ID: mdl-12019773

ABSTRACT

Quantitation of the level of specific mRNA involves the isolation of total RNA or poly(A)+ RNA as a starting materiaL Thus, this result is the sum of the transcription and degradation of mRNA. Here we report a rapid, sensitive, and high-throughput methodology for gene expression analysis from nuclear poly(A)+ RNA via the reduction of the cytosolic components. The cells were first trapped on the glass fiber membranes of 96-well filter plates and subsequently exposed to non-ionic detergent to achieve cell membrane permeation. The cytosolic components, which contain preexisting mRNA, were removed by washing with the appropriate buffer, while nuclei remained in the filter plates. Lysis buffer was then used to release nuclear mRNA, which was collected on oligo(dT)-immobilized PCR plates for the capture of poly(A)+ RNA, on which RT-PCR was performed. The reduction of the cytosolic components and the preservation of the nuclear components were confirmed by electron microscopy, agarose gel electrophoresis, PCR of mtDNA, and RT-PCR of pre-splicing immature beta-actin poly(A)+ RNA. Using this method, we clearly identified UVC-induced p21 gene expression that is not detectable with conventional whole cell methods.


Subject(s)
Cell Nucleus/genetics , Gene Expression Regulation , Molecular Biology/methods , RNA, Messenger/genetics , Detergents , Humans , K562 Cells , Octoxynol , Polyethylene Glycols , RNA, Messenger/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity , U937 Cells
7.
Jpn J Cancer Res ; 92(12): 1278-83, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11749692

ABSTRACT

We previously reported p53 mutations to be frequent (greater than 70%), whereas both H-ras mutations and microsatellite instability (MSI) were infrequent (about 10%), in urinary bladder carcinomas (UBCs) and their metastatic foci in the N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN)-induced mouse urothelial carcinogenesis model. In the present study, an analysis of p53 and H-ras mutations as well as MSI was performed on 12 renal pelvic carcinomas (RPCs) and 8 metastatic or invading foci produced by the same experimental procedure. Histologically, 10 of the RPCs were transitional cell carcinomas and the remaining 2 were squamous cell carcinomas. p53 mutations were infrequent and only found in one primary RPC (8%), its metastatic foci and an invading lesion in another animal (in a total 2 of 12; 17%). H-ras mutations were slightly more frequent (found in 3 of 12 animals; 25%), 4 of 5 involving codon 44, GTG to GCG, not a hot-spot reported for human cancers. In two cases, H-ras mutations were confined to lung metastasis and not detectable in their primary RPCs. MSI analysis was available for 6 pairs of primary RPCs and their metastatic foci, and 4 animals (67%) had MSI at one or more microsatellite loci. Overall, the distribution of genetic alterations differed from that in UBCs produced by the same experimental protocol. The results thus suggest that different genetic pathways may participate in carcinogenesis of the upper and lower urinary tract due to BBN.


Subject(s)
Butylhydroxybutylnitrosamine/pharmacology , Genes, p53/genetics , Genes, ras/genetics , Kidney Neoplasms/genetics , Microsatellite Repeats/genetics , Mutation/genetics , Urinary Bladder Neoplasms/genetics , Animals , DNA Mutational Analysis , Kidney Neoplasms/chemically induced , Kidney Neoplasms/pathology , Mice , Mutagenesis/drug effects , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational , Urinary Bladder Neoplasms/chemically induced
8.
Int J Clin Oncol ; 6(5): 215-20, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11723742

ABSTRACT

BACKGROUND: To prevent tumor metastasis, we administered the cell-binding domain of fibronectin, in combination with the angiogenesis inhibitor TNP-470, to mice with hepatic metastasis. We then assessed the prevention of tumor metastasis resulting from the inhibition of adhesive interactions and the inhibition of angiogenesis. METHODS: A hepatic metastasis model was created by injecting 1 x 10(3) colon 26/TC-1 cells into the anterior mesenteric vein of CDF1 mice. The cell-binding domain obtained from fibronectin included the Arg-Gly-Asp (RGD) sequence. A fibronectin-binding domain (FND)-treated group, an FND plus TNP-470 group, and a control group were established. The animals were killed 4 weeks after the injections of the treatment agents had been completed and the number of metastatic liver nodules was counted. In a simultaneous experiment with the same design, the mice were not killed at 4 weeks, and their survival was observed. RESULTS: The mean number of nodules in the FND plus TNP-470 group was significantly lower than that in the control group (P = 0.019337). The inhibition rate was 51% in the FND group, 60% in the FND 10 micrograms plus TNP-470 10 mg/kg group, and 64% in the FND 10 micrograms plus TNP-470 100 mg/kg group compared with the control group. Mice from the FND group that were not killed died after 6-8 weeks, but mice from the FND plus TNP-470 group died after 8-12 weeks. CONCLUSION: The cell-binding domain of fibronectin may, potentially, be an effective form of antiadhesive therapy that competes with native adhesion molecules and blocks adhesion during the metastatic process. When the cell-binding domain of fibronectin is combined with TNP-470 to inhibit angiogenesis, more effective inhibition of metastatic tumor growth and prolongation of survival can be achieved than after treatment with the cell-binding domain alone.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Colorectal Neoplasms , Fibronectins/chemistry , Liver Neoplasms/prevention & control , Liver Neoplasms/secondary , Oligopeptides/therapeutic use , Sesquiterpenes/therapeutic use , Animals , Cyclohexanes , Disease Models, Animal , Male , Mice , O-(Chloroacetylcarbamoyl)fumagillol , Tumor Cells, Cultured
9.
Clin Oral Investig ; 5(3): 194-8, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11642565

ABSTRACT

Humoral hypercalcemia of malignancy (HHM) is one of the most common metabolic complications associated with cancer. A retrospective study of hypercalcemia in patients with squamous cell carcinoma of the oral cavity was undertaken. All patients were periodically monitored for their serum level of calcium (Ca). Hypercalcemia was defined as a serum Ca concentration higher than 11 mg/dl of the correction for serum albumin concentration. The serum levels of parathyroid hormone related protein (PTH-rP) were also measured by radioimmunoassay. Hypercalcemia was detected in ten of 246 patients (4.1%). All ten patients were at an advanced stage of oral squamous cell carcinoma (SCC, Stage IVA, IVB or IVC). In these ten patients, the serum level of PTH-rP was significantly elevated, 238 +/- 91 pmol/l (range, 108-380 pmol/L). The patients with HHM who underwent antihypercalcemic therapy showed reduced Ca levels relating to PTH-rP levels; however, the Ca concentration was temporarily improved after anti-hypercalcemic treatment. The median survival time after diagnosis of HHM was only 55.8 +/- 19.9 days (range, 27-86 days). HHM in oral cancer is likely attributable to PTH-rP, and its occurrence appears to be an ominous prognostic sign.


Subject(s)
Carcinoma, Squamous Cell/complications , Hypercalcemia/etiology , Mouth Neoplasms/complications , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/blood , Calcitonin/therapeutic use , Carcinoma, Squamous Cell/blood , Carcinoma, Squamous Cell/pathology , Diphosphonates/therapeutic use , Female , Humans , Hypercalcemia/drug therapy , Male , Middle Aged , Mouth Neoplasms/blood , Mouth Neoplasms/pathology , Neoplasm Proteins/blood , Neoplasm Staging , Pamidronate , Parathyroid Hormone-Related Protein , Prognosis , Proteins/analysis
10.
Acta Otolaryngol Suppl ; 545: 136-9, 2001.
Article in English | MEDLINE | ID: mdl-11677727

ABSTRACT

Cerebral degenerative diseases produce a variety of abnormal neuro-otological findings on electronystamography (ENG). To assess their diagnostic value and determine which manifestations are helpful in making a diagnosis, ENG findings from 72 cases of confirmed cerebral degenerative disease were analyzed. We observed a high incidence of saccadic pursuit and upward ocular dysmetria, which is likely to be useful in diagnosing cerebral degenerative disease. In contrast, moderate incidences of horizontal ocular dysmetria, gaze-evoked and rebound nystagmus, vertical positioning nystagmus and impaired visual suppression appeared to reflect the degree of dysfunction, while optokinetic nystagmus appeared to reflect both the presence of disease and its severity. Cases of spinocerebellar ataxia 6 and spinocerebellar ataxia 3 tended to produce horizontal and vertical gaze-evoked nystagmus, whereas progressive supranuclear palsy produced a higher incidence of upward gaze-evoked nystagmus, and positioning nystagmus at the sagittal plane appeared frequently in cases of non-hereditary spinocerebellar degeneration.


Subject(s)
Spinocerebellar Ataxias/diagnosis , Spinocerebellar Ataxias/physiopathology , Electronystagmography/methods , Female , Humans , Male , Middle Aged , Nystagmus, Optokinetic/physiology , Saccades/physiology , Severity of Illness Index
11.
J Urol ; 165(5): 1468-72, 2001 May.
Article in English | MEDLINE | ID: mdl-11342898

ABSTRACT

PURPOSE: Cyclooxygenase-2 is considered to have an important role in the development of metastasis in cancer due to angiogenesis function. The expression of cyclooxygenase-2 was found to be up-regulated in colorectal carcinoma and other cancers. We investigated cyclooxygenase-1 and 2 expressions in patients with bladder cancer, chronic cystitis and normal bladder. MATERIALS AND METHODS: A total of 118 specimens were obtained from patients treated at Osaka City University Hospital for bladder cancer, including 10 with chronic cystitis and 8 with normal bladder tissue. Immunohistochemistry, with affinity purified antibodies against human cyclooxygenase-1 and 2 that did not have cross-reactivity with each other, and reverse transcriptase polymerase chain reaction to study the messenger RNA expression were performed. RESULTS: Although no marked expression of cyclooxygenase-2 was observed in the normal bladder, it was slightly seen in infiltrative inflammatory cells of chronic cystitis, and a higher expression was found in cancer cells. The extent and intensity of immunoreactive cyclooxygenase-2 polypeptides in cancer cells was statistically much greater than those in cells from normal bladder tissue. Moreover, correlation between cyclooxygenase-2 expression and tissue type or progression of bladder cancer was observed. Cyclooxygenase-2 expression was higher in grade 3 bladder cancer than in grade 1, and was higher in advanced than in early stage cancer. CONCLUSIONS: These results demonstrate that generated cyclooxygenase-2 in the cells of patients with bladder cancer might be significant in the proliferation of bladder malignant cells and development of invasions.


Subject(s)
Biomarkers, Tumor/analysis , Isoenzymes/analysis , Prostaglandin-Endoperoxide Synthases/analysis , Urinary Bladder Neoplasms/enzymology , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/enzymology , Carcinoma, Squamous Cell/pathology , Carcinoma, Transitional Cell/enzymology , Carcinoma, Transitional Cell/pathology , Chronic Disease , Cyclooxygenase 1 , Cyclooxygenase 2 , Cystitis/enzymology , Female , Humans , Immunohistochemistry , Isoenzymes/genetics , Male , Membrane Proteins , Middle Aged , Prostaglandin-Endoperoxide Synthases/genetics , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Urinary Bladder/enzymology , Urinary Bladder Neoplasms/pathology
12.
J Immunol ; 166(1): 617-23, 2001 Jan 01.
Article in English | MEDLINE | ID: mdl-11123345

ABSTRACT

To investigate the crucial role of platelet-derived thromboxane A(2) (TXA(2)) in initiating Ag-specific contact sensitivity (CS), a platelet-dependent CS model using genetically mast cell-deficient W/W(v) mice, was provided. In vivo treatment with BAYu3405, a TXA(2) receptor antagonist, markedly suppressed CS responses in a dose-dependent manner. This inhibitory effect occurred when BAYu3405 was administered before an early initiating phase, suggesting that TXA(2) may be a potent initiator of platelet-mediated CS responses. When platelets were pretreated with BAYu3405 in vitro, platelet aggregation as well as serotonin release, which is able to induce the early phase response allowing local recruitment of CS effector T cells due to direct activation of vascular endothelial cells, was inhibited. The addition of U46619, a TXA(2) agonist, or a mixture of platelets and thrombin-enhanced expression of both ICAM-1 and VCAM-1 on isolated mouse aortic endothelial cells, which was completely abolished by pretreatment with BAYu3405. Furthermore, intradermal injection of U46619 into the ear of platelet-depleted mice led to CS responses with marked expression of ICAM-1 and VCAM-1 on the vascular endothelium. These findings suggest that TXA(2) generated from platelets activated with Ag may mediate initiation of CS responses through inducing serotonin release from platelets and the subsequent aggregation and up-regulated expression of ICAM-1 and VCAM-1 on vascular endothelial cells.


Subject(s)
Blood Platelets/immunology , Dermatitis, Contact/immunology , Endothelium, Vascular/immunology , Platelet Activation/immunology , Thromboxane A2/physiology , 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid/administration & dosage , Adenosine Triphosphate/antagonists & inhibitors , Adenosine Triphosphate/metabolism , Animals , Aorta, Abdominal , Aorta, Thoracic , Blood Platelets/drug effects , Blood Platelets/metabolism , Carbazoles/administration & dosage , Cells, Cultured , Dermatitis, Contact/blood , Dermatitis, Contact/prevention & control , Ear/blood supply , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Humans , Immune Sera/administration & dosage , Injections, Intradermal , Injections, Intraperitoneal , Injections, Intravenous , Intercellular Adhesion Molecule-1/biosynthesis , Male , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Platelet Activation/drug effects , Platelet Aggregation Inhibitors/administration & dosage , Receptors, Thromboxane/antagonists & inhibitors , Serotonin/metabolism , Sulfonamides/administration & dosage , Thromboxane A2/agonists , Vascular Cell Adhesion Molecule-1/biosynthesis , Vasoconstrictor Agents/administration & dosage
13.
Hinyokika Kiyo ; 46(4): 277-8, 2000 Apr.
Article in Japanese | MEDLINE | ID: mdl-10845162

ABSTRACT

A 20-year-old men fell from a ladder in 1995, striking his perineum strongly, and macroscopic hematuria with painful urination lasted for several days. Subsequently, swelling of the perineum on urination continued to occur. However, he did not seek medical treatment until July 1997, when he consulted our medical institution. A diverticulum-like change was found in the bulbous urethra on urethrocystography, and a tear in the same position on urethroscopy. On September 22, 1997, surgery was performed after constructing a cystostomy, the tear was located using a urethroscope, and closed through a perineal approach. At 14 days after surgery, there was extra-urethral leakage of contrast media on voiding cystourethrography, and at 28 days after surgery, the findings showed improvement. Since then, he has been free of the preoperative symptoms.


Subject(s)
Diverticulum/surgery , Urethra/injuries , Urethral Diseases/surgery , Wounds, Nonpenetrating/complications , Accidental Falls , Adult , Cystostomy , Diverticulum/etiology , Humans , Male , Time Factors , Treatment Outcome , Urethral Diseases/etiology
14.
J Pharmacol Exp Ther ; 292(3): 1008-14, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10688617

ABSTRACT

Recent studies from this laboratory have demonstrated that L-tryptophan, after oxidation either by UV-irradiation or ozone, induces aryl hydrocarbon receptor (AhR) activation and binding of the liganded AhR complex to its specific DNA recognition site, thereby initiating transcription of the cytochrome P-450 1a1 (Cyp1a1) gene with concomitant increase of CYP1A1 protein and 7-ethoxyresorufin O-deethylase activity in wild-type mouse hepatoma cells, Hepa lclc7 (Hepa-1), in culture. Temporary inhibition of protein synthesis by cycloheximide resulted in superinduction of oxidized tryptophan-inducible CYP1A1 mRNA, protein, and 7-ethoxyresorufin O-deethylase activity in Hepa-1 cells. In the present communication, the results obtained by immunoblot analyses with monoclonal CYP1A1/1A2 antibody (NIH 1-7-1) demonstrate that both UV- or ozone-oxidized tryptophan also induce CYP1A2 protein in Hepa-1 cells. CYP1A2 mRNA, detected by reverse transcription-polymerase chain reaction, was markedly induced in the UV- or ozone-oxidized tryptophan-treated cells. Temporary inhibition of protein synthesis by cycloheximide further induced oxidized tryptophan-inducible CYP1A2 mRNA as well as the protein in Hepa-1 cells. This is the first report demonstrating the induction of CYP1A2 mRNA and protein in Hepa-1 cells.


Subject(s)
Cytochrome P-450 CYP1A2/biosynthesis , Tryptophan/pharmacology , Animals , Cycloheximide/pharmacology , Cytochrome P-450 CYP1A1/biosynthesis , Cytochrome P-450 CYP1A2/genetics , DNA, Complementary/chemistry , Enzyme Induction/drug effects , Mice , Oxidation-Reduction , RNA, Messenger/analysis , Receptors, Aryl Hydrocarbon/physiology , Tumor Cells, Cultured
15.
J Gastroenterol Hepatol ; 14(10): 997-1003, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10530496

ABSTRACT

BACKGROUND: The induction of tumour-specific immunity is important for advanced cancer therapy. There are many molecules, including costimulatory molecules, that have been identified as the activator for tumour-specific T cells. METHODS: To induce autologous tumour-specific cytotoxic T lymphocytes (CTL) more effectively, we studied whether the expression of the B7 gene may render human colon cancer cells able to stimulate autologous peripheral blood mononuclear cells (PBMC) to become tumour-specific cytotoxic T cells. After the establishment of a B7.1 gene transfected tumour cell line, Cw2/B7.1, we first examined its stimulatory effect on autologous PBMC and subsequently, its effect on the induction of parental cell (Cw2)-specific CTL. RESULTS: The results showed that Cw2/B7.1 had a more potent stimulatory effect on PBMC for the induction of both proliferation and cytotoxicity than Cw2. By adding a low dose of interleukin-2, Cw2/B7.1-activated killer cell activity was significantly increased. The specificity of Cw2/B7.1-activated killer cells was demonstrated by the absence of their cytotoxicity to either human lymphocyte antigen (HLA)-A33 identical (ORF) or HLA-non-identical (MT) allogenic colon cancer cell lines. Furthermore, such Cw2-specific cytotoxic activity was significantly reduced by the deletion of CD8+ cells but not CD4+ cells, indicating that these killer cells were mainly CD8+ T cells. CONCLUSIONS: Thus, our results demonstrate that, by using B7.1 gene-transfected tumour cell lines, we effectively induced autologous tumour-specific CTL. These results will provide us with new tools for adoptive immunotherapy for colon cancer patients.


Subject(s)
B7-1 Antigen/genetics , Colonic Neoplasms/genetics , Colonic Neoplasms/immunology , Lymphocytes, Tumor-Infiltrating/immunology , T-Lymphocytes, Cytotoxic/immunology , B7-1 Antigen/biosynthesis , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cell Division/drug effects , Cell Division/immunology , Cells, Cultured , Colonic Neoplasms/pathology , Cytotoxicity Tests, Immunologic , Epitopes , Female , Flow Cytometry , Histocompatibility Antigens Class I/biosynthesis , Humans , Intercellular Adhesion Molecule-1/biosynthesis , Interleukin-2/pharmacology , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Lymphocyte Activation/genetics , Lymphocytes, Tumor-Infiltrating/drug effects , Middle Aged , Transfection
16.
Cancer Chemother Pharmacol ; 43 Suppl: S52-5, 1999.
Article in English | MEDLINE | ID: mdl-10357559

ABSTRACT

Matrilysin (MMP-7) is the smallest member of the matrix metalloproteinase (MMP) family. It is frequently expressed in various types of cancer including colon, stomach, prostate, and brain cancers. Previous studies have suggested that matrilysin plays important roles in the progression and metastasis of colon cancer. Recently, we have examined the effects of a matrilysin-specific antisense phosphorothioate oligodeoxyribonucleotide on in vitro invasion and liver metastasis in nude mice of two human colon carcinoma cell lines (CaR-1 and WiDr). In culture, the antisense oligonucleotide effectively inhibited both the secretion of matrilysin by CaR-1 cells and their in vitro invasion through a reconstituted basement membrane. In a nude mouse model, the antisense oligonucleotide potently suppressed the experimental liver metastasis of WiDr cells from the spleen. These results suggest that matrilysin has an important role in the liver metastasis of human colon cancer and that matrilysin antisense oligonucleotides have therapeutic potential for the prevention of metastasis.


Subject(s)
Colonic Neoplasms/pathology , Metalloendopeptidases/metabolism , Neoplasm Metastasis/prevention & control , Oligonucleotides, Antisense/therapeutic use , Animals , Humans , Matrix Metalloproteinase 7 , Mice
17.
Endocrinology ; 140(7): 3125-32, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10385405

ABSTRACT

Administration of activin A, a member of the transforming growth factor-beta superfamily inhibits hepatocyte proliferation in vitro and reduces liver mass in vivo. However, a role of endogenous activin A in local growth modulation has not been established in any system. The aim of this study was to examine the production of activin A in the human hepatoma cell line HLF and to explore a possible autocrine role of activin as a cell growth inhibitor by blocking production of endogenous activin using antisense oligodeoxynucleotides. Administration of exogenous activin A suppressed HLF cell growth, and immunoreactive activin A was shown to be produced in the cells at confluency by Western blotting analysis. Cells were exposed to phosphorothioate-modified oligodeoxynucleotides, synthesized with antisense or randomly shuffled base sequences of activin betaA subunit messenger RNA, under serum-free conditions. Uptake of the oligodeoxynucleotides into the cells was confirmed by use of fluorescein isothiocyanate-labeled oligodeoxynucleotides. Administration of antisense oligodeoxynucleotides reduced activin A production as confirmed by both competitive PCR and Western blotting. Activin betaA antisense oligodeoxynucleotides significantly increased cell proliferation compared with controls. These findings are consistent with the existence of an autocrine role of activin A as an inhibitor of hepatocyte proliferation.


Subject(s)
Autocrine Communication/drug effects , Inhibins/genetics , Inhibins/physiology , Liver Neoplasms/pathology , Liver Neoplasms/physiopathology , Oligonucleotides, Antisense/pharmacology , Activins , Cell Division/drug effects , Cell Division/physiology , Humans , Inhibins/metabolism , Liver Neoplasms/metabolism , Oligonucleotides, Antisense/chemistry , Oligonucleotides, Antisense/pharmacokinetics , Transforming Growth Factor beta/pharmacology , Tumor Cells, Cultured
18.
Eur J Pharmacol ; 370(2): 205-9, 1999 Apr 09.
Article in English | MEDLINE | ID: mdl-10323271

ABSTRACT

1-Benzyl-4-[N-(3-isopropoxy-2-pyridinyl)-N-methyl]-amino-piperidine ([3H]U-101958), a dopamine D4 receptor ligand, was found to bind to a large sigma1 receptor-like component in human cerebellum and SK-N-MC neuroblastoma cells with high affinity (2-4 nM Kd). By contrast, binding to dopamine D4 receptors represented 10% or less of the sigma1 receptor-like site. Considering that U-101958 has been characterized as either a dopamine D4 receptor agonist or antagonist, depending on the system under study, the observation that U-101958 also binds to sigma1 receptor-like sites is important for accurate interpretation of the pharmacological actions of this compound. [3H]U-101958 may be a useful radioligand for sigma1 rather than dopamine D4 receptor sites.


Subject(s)
Aminopyridines/metabolism , Cerebellum/metabolism , Dopamine Agents/metabolism , Neuroblastoma/metabolism , Piperidines/metabolism , Receptors, Dopamine D2/metabolism , Receptors, sigma/metabolism , Binding, Competitive , Culture Techniques , Humans , Radioligand Assay , Receptors, Dopamine D4 , Reverse Transcriptase Polymerase Chain Reaction , Sigma-1 Receptor
19.
Clin Chem ; 44(11): 2249-55, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9799750

ABSTRACT

Two major components of rRNA (18S and 28S rRNA) were separated by electrophoresis in injection-molded acrylic chips with a microchannel 100 microm in width, 40 microm in depth, and with 1 cm of separation distance. Microchannels were filled with 4 g/L hydroxypropylmethylcellulose as sieving polymer and 5 mg/L ethidium bromide for RNA staining. The fluorescent signals were detected by a fluorescent microscope equipped with a photometer and 590 nm emission filter. The assay is rapid (<3 min), reproducible, RNase-free, and requires only 1-2 microL of sample. The detection limit was approximately 10 mg/L (10 ng/microL), 100-fold lower than that for conventional agarose gel electrophoresis. Because only 0.1 nL of the loaded sample was used for electrophoresis, the detectable peaks of rRNA in the separation were derived from less RNA than in a single cell. Because the quality of RNA is critical for RNA-related diagnostic tests, disposable plastic chips will be useful for quality assessment of RNA.


Subject(s)
Miniaturization , RNA, Ribosomal, 18S/analysis , RNA, Ribosomal, 28S/analysis , Animals , DNA/analysis , Electrophoresis, Agar Gel/instrumentation , Electrophoresis, Agar Gel/methods , Humans , Lung/cytology , Lung/metabolism , Microscopy, Fluorescence , Plastics , Rats , Reproducibility of Results , Sensitivity and Specificity , U937 Cells
20.
Clin Chem ; 44(11): 2256-63, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9799751

ABSTRACT

To simplify gene expression analysis, oligo(dT)-immobilized polypropylene microplates were used serially to capture mRNA, synthesize cDNA, and amplify specific genes. The amounts of immobilized oligonucleotide, hybridized mRNA, and synthesized cDNA were quantified fluorometrically using either Yoyo-1 or AttoPhos. The immobilized oligonucleotides captured approximately 40-55% of mRNA directly from crude cell lysates. Hybridized mRNA was then amplified by one-step reverse transcription (RT)-PCR with rTth polymerase or two-step PCR with initial cDNA synthesis followed by PCR, where the latter exhibited more sensitivity. In two-step RT-PCR, microplates can be reused for multiple PCRs with the same or different primer sets because synthesized cDNA was covalently attached to the plates at its 5' end. We believe this microplate may be acceptable as a platform for various mRNA expression analyses, including basic research, drug screening, and molecular toxicology, as well as for molecular pathological diagnostics.


Subject(s)
Oligodeoxyribonucleotides , RNA, Messenger/analysis , Animals , DNA/analysis , DNA, Complementary/analysis , DNA, Complementary/chemical synthesis , Globins/genetics , Humans , K562 Cells , Miniaturization , Nucleic Acid Hybridization , Polypropylenes , RNA, Neoplasm/analysis , RNA, Ribosomal/analysis , RNA, Transfer/analysis , Rabbits , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...